Luteinizing hormone supplementation with human menopausal gonadotropin versus low dose human chorionic gonadotropin during ovarian stimulation does not affect live birth rates after fresh and frozen embryo transfer
Journal of Obstetrics and Gynaecology Research · 2024-10 · 50 (10) · 1935-1944
DOI: 10.1111/jog.16065 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 08.09.2024. Verfasst von Linnea Fischer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Ovulation Induction, Embryo Transfer, Chorionic Gonadotropin, Menotropins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Aim
Luteinizing hormone (LH) plays an important role in ovarian follicle maturation. Human menopausal gonadotropin (hMG) or low dose human chorionic gonadotropin (hCG) can provide LH supplementation during in vitro fertilization (IVF) ovarian stimulation, though studies directly comparing their impact on IVF outcomes are limited. The aim of the study was to determine whether LH supplementation with hMG versus low dose hCG during IVF stimulation affects live birth rate.
Methods
Fresh and frozen embryo transfers (ET) from 2017 to 2021 after standard long or antagonist protocols supplemented with hMG (75–250 IU) or low dose hCG (50–100 IU) during stimulation cycles in our academic center were included. Statistical analysis was performed with T ‐tests, Mann–Whitney U tests, Chi‐square, and multiple linear and logistic regression.
Results
Four hundred and sixty eight unique stimulation cycles resulting in 213 fresh and 412 frozen embryo transfers were analyzed. There was a lower mature oocyte yield (10.9 vs. 11.8, p = 0.044) but similar high‐quality blastocyst yield (3.6 vs. 3.9, p = 0.11) for hMG vs low dose hCG. Live birth rates per transfer were comparable for fresh (42% vs. 49%, p = 0.24) and frozen (46% vs. 53%, p = 0.45) embryo transfers. Multiple logistic regressions showed no association between supplemental gonadotropin and live birth for both fresh and frozen embryo transfers.
Conclusion
Fresh and frozen IVF‐ET pregnancy outcomes were comparable after hMG versus low dose hCG supplementation, suggesting flexibility in supplemental LH dosing regimens that may address patient or physician preference or cost concerns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
- Division of Reproductive Endocrinology and Infertility, University Hospitals Fertility Center, Cleveland, Ohio, USA.
ORCID-Profile: Linnea Fischer
Zitieren
APA
Fischer, L., Chung, R. K., Kim, S. T., Flyckt, R., & Weinerman, R. (2024). Luteinizing hormone supplementation with human menopausal gonadotropin versus low dose human chorionic gonadotropin during ovarian stimulation does not affect live birth rates after fresh and frozen embryo transfer. Journal of Obstetrics and Gynaecology Research, 50(10), 1935-1944. https://doi.org/10.1111/jog.16065
Vancouver
Fischer L, Chung RK, Kim ST, Flyckt R, Weinerman R. Luteinizing hormone supplementation with human menopausal gonadotropin versus low dose human chorionic gonadotropin during ovarian stimulation does not affect live birth rates after fresh and frozen embryo transfer. Journal of Obstetrics and Gynaecology Research. 2024;50(10):1935-1944. doi:10.1111/jog.16065
BibTeX
@article{Fischer2024,
author = {Fischer, Linnea and Chung, Rebecca K and Kim, Sung Tae and Flyckt, Rebecca and Weinerman, Rachel},
title = {Luteinizing hormone supplementation with human menopausal gonadotropin versus low dose human chorionic gonadotropin during ovarian stimulation does not affect live birth rates after fresh and frozen embryo transfer},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2024},
volume = {50},
number = {10},
pages = {1935--1944},
doi = {10.1111/jog.16065}
}
EUVIMED